Takayasu arteritis: Year of the Zebra 2026

Watch video only
Takayasu arteritis is a rare inflammatory disease affecting large arteries, particularly the aorta and its major branches, including the carotid and subclavian arteries which supply blood to the head, neck, and arms.
It predominantly affects young females, especially those of Asian descent, and typically begins before age 40. The exact cause is unknown, but it's suspected to involve an autoimmune process in which immune cells mistakenly attack arterial walls.
This chronic inflammation causes two main problems. First, it causes the vessel walls to become thickened, which gradually narrows the space for the blood to flow through.
Second, despite this thickening, the arterial walls become structurally weaker because most of the elastic fibers and smooth muscle cells that allow the arteries to stretch and recoil get replaced by scar tissue.
Over time, these structural changes can weaken the vessel wall. The affected arteries become less flexible and prone to aneurysms, which are balloon-like bulges in the weakened areas that risk rupture.
This results in an overall reduction of blood flow to the arms and head. Clinically, patients initially present with unspecific systemic symptoms which can include fever, weight loss, night sweats, malaise, and fatigue.
As the disease progresses, the blood vessels become damaged. If the inflammation happens around the branches that serve the arms, it can cause a weak or non-existent pulse on one side of the body, which is why Takayasu arteritis is also called the pulseless disease.
This can also lead to a BP discrepancy between the arms that's greater than 10 millimeters of mercury, as well as bruits, which are whooshing sounds heard over narrowed arteries.
Decreased blood flow to the arms can also cause claudication, meaning pain or muscle fatigue that gets worse during activity.
On the other hand, inflammation affecting the arteries that supply the head and neck can cause visual disturbances and neurological symptoms such as headaches, dizziness, fainting, or stroke in severe cases.
Takayasu arteritis can also involve the lower aorta, especially the renal arteries, which causes systemic high BP. In Tagayasu arteritis, lab tests often show elevated pro-inflammatory markers such as erythrocyte sedimentation rate and C-reactive protein.
Imaging studies such as an MRI or a CT angiogram look specifically at blood vessels and are essential to show thickening of the artery walls, areas of narrowing, or aneurysms.
Because affected segments often alternate with normal appearing vessels, imaging of the entire aorta and its branches is recommended to avoid missing any affected vessels.
Unlike some other forms of vasculitis, a biopsy is usually not needed to confirm the diagnosis. Initially treatment includes high doses of corticosteroids.
The corticosteroids are then gradually tapered while additional immunosuppressive agents such as methotrexate are introduced to help maintain disease control and reduce steroid exposure.
Beyond standard medications, several newer treatments are being used for relapsing or refractory Takayasu arteritis, including TNF inhibitors such as infliximab or adalimumab.
Because the course is often chronic and relapsing, long-term immunosuppressive therapy is generally necessary to control the disease and prevent irreversible damage.
All right, as a quick recap, Takayasu arteritis is a form of large vessel vasculitis that mainly affects the aorta and usually affects females less than 40 years, especially those of Asian descent.
It's characterized by chronic inflammation of arterial walls which can lead to thickening, occlusion, and development of aneurysms.
Treatment focuses on suppressing inflammation to prevent disease progression using corticosteroids and other immunosuppressive medications or biological agents.
Takayasu arteritis: Year of the Zebra 2026: Video, Causes, & Meaning | Osmosis